New York · 2025 Regular Session · Bill
S 6523: Requires insurance companies to reimburse all health care practitioners at the same rate for cervical cytology screening
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 6523 is a bill introduced in the New York Senate on March 17, 2025. According to its official title, it concerns: Requires insurance companies to reimburse all health care practitioners at the same rate for cervical cytology screening. Primary sponsor: Cordell Cleare (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO INSURANCE.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires insurance companies to reimburse all health care practitioners at the same rate for cervical cytology screening, including the preparation of a Pap smear; prohibits health care practitioners from refusing to provide a Pap smear during a regular annual checkup if such patient has not had a Pap smear done in the preceding twelve months.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Cordell Cleare | Primary sponsor | Democratic | Senate | 30 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO INSURANCE
- REFERRED TO INSURANCE